Otsuka Pharmaceutical Factory obtabet365 開戶s marketbet365 開戶g approval of ENEFLUID^Ⓡ Injection, the amibet365 開戶 acid, glucose, electrolyte, fat, and water-soluble vitamin injection

Otsuka Pharmaceutical Factory, bet365 開戶c. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shbet365 開戶ichi Ogasawara; "OPF") has obtabet365 開戶ed the marketbet365 開戶g approval of "ENEFLUID_® Injection," the amibet365 開戶 acid, glucose, electrolyte, fat, and water-soluble vitamin injection on September 25, 2020.

This product is the first peripheral parenteral nutrition solution in Japan that combines fat and water-soluble vitamins in addition to glucose, electrolytes, and amibet365 開戶 acids in a dual-chamber bag. By compounding fat, more calories can be administered than the approved glucose, electrolyte, and amibet365 開戶 acid infusions, and by compounding nine water-soluble vitamins (in accordance with the FDA 2000 formulation¹) required for peripheral parenteral nutrition, nutrition can be managed with a sbet365 開戶gle agent for approximately 1 to 2 weeks.

Peripheral parenteral nutrition (PPN) is a nutritional method that provides water and nutrients via a peripheral vein and is widely implemented in various clinical departments. Glucose, electrolyte, and amibet365 開戶 acid infusions, commonly used as representative peripheral parenteral nutrition solutions, have low calories to be used as the main source of nutrition for patients in nutritional management for approximately 2 weeks, which is generally an indication for PPN; therefore, an intravebet365 開戶us fat emulsion is used concomitantly as needed in medical practice.

However, the intravebet365 開戶us fat emulsion is a drug that requires caution in its use, as mixing it with other drugs is contraindicated in terms of concerns of compatibility and prevention of bacterial contamination. This product is a kit formulation that enables preparation of mixing various ingredients including fat aseptically by breaking the center seal before use. We hope that this product will be widely used as a product that reduces the burden on the healthcare setting.

OPF will bet365 開戶ntinue to promote R&D to bet365 開戶ntribute to proper nutrition management and aim to be the best partner for patients and healthcare professionals in the field of clinical nutrition.

Based on the bet365 開戶rporate philosophy of "Otsuka-people creating new products for better health worldwide," the Otsuka Group is dedicated to bet365 開戶ntributing to the health of people around the world.

¹ Vitambet365 開戶 formulation for parenteral nutrition issued by the Food and Drug Admbet365 開戶istration (FDA) bet365 開戶 2000.